🔴 Gilead Sciences is trading 5.1% down today amid biotech sector sell-off and geopolitical tensions

Gilead Sciences is trading 5.1% down at ARS 50,750.00 as part of a broader pullback in biotechnology and risk assets.

• Biotechnology stocks are down more than 2% as market sentiment turns cautious due to escalating U.S.–Iran tensions and risk-off trading.
• The decline occurs amid mixed moves across major U.S. indices with no fresh, stock-specific news or corporate events driving the move.
• The price action appears to be part of a sector-wide trend rather than an idiosyncratic event for the company.